Potential use of antibodies to provide an earlier indication of lymphatic filariasis resurgence in post–mass drug ad ministration surveillance in American Samoa

por Cadavid Restrepo, Angela M., Gass, Katherine, Won, Kimberly Y., Sheel, Meru, Robinson, Keri, Graves, Patricia M., Fuimaono, Saipale, Lau, Colleen L
Publicado 2022

Use of Antibody Tools to Provide Serologic Evidence of Elimination of Lymphatic Filariasis in The Gambia

por Won, Kimberly Y., Sambou, Sana, Barry, Amanda, Robinson, Keri, Jaye, Momodou, Sanneh, Bakary, Sanyang, Abdoulie, Gass, Katherine, Lammie, Patrick J., Rebollo, Maria
Publicado 2018

Positive-case follow up for lymphatic filariasis after a transmission assessment survey in Haiti

por Hast, Marisa A., Javel, Alain, Denis, Eurica, Barbre, Kira, Rigodon, Jonas, Robinson, Keri, Brant, Tara A., Wiegand, Ryan, Gass, Katherine, Telfort, Marc Aurèle, Dubray, Christine
Publicado 2022

Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa

por Won, Kimberly Y., Robinson, Keri, Hamlin, Katy L., Tufa, Joseph, Seespesara, Margaret, Wiegand, Ryan E., Gass, Katherine, Kubofcik, Joseph, Nutman, Thomas B., Lammie, Patrick J., Fuimaono, Saipale
Publicado 2018

Notes from the Field: Impact of a Mass Drug Administration Campaign Using a Novel Three-Drug Regimen on Lymphatic Filariasis Antigenemia — American Samoa, 2019

por Hast, Marisa A., Tufa, Aifili, Brant, Tara A., Suiaunoa-Scanlan, Lynette, Camacho, Janet, Vaifanua-Leo, June, Robinson, Keri, Dodd, Emily, Sili, Ben, Lees, Loretta S., Won, Kimberly Y., Utu, Fara
Publicado 2020